Ironwood Pharmaceuticals | IRWD - Loan Capital


Ironwood Pharmaceuticals reported $583.99M in Loan Capital for its fiscal quarter ending in December of 2024.





Loan Capital Change Date
Acadia Pharmaceuticals USD 0 0 Mar/2025
Agios Pharmaceuticals USD 1.06M 0 Sep/2022
Akebia Therapeutics USD 36.39M 11.85M Mar/2026
Almirall EUR 324.81M 61.32M Dec/2025
Alnylam Pharmaceuticals USD 2.48B 931K Mar/2026
Ardelyx USD 202.83M 696K Dec/2025
Astellas Pharma JPY 320B 0 Mar/2026
AstraZeneca USD 25.96B 177M Mar/2026
Charles River Laboratories USD 2.66B 526.77M Mar/2026
Coherus Biosciences USD 51.08M 496K Dec/2025
Emergent BioSolutions USD 446.5M 1.7M Dec/2023
Esperion Therapeutics USD 457.65M 9.5M Dec/2025
Halozyme Therapeutics USD 1.94B 206.73M Mar/2026
Incyte USD 29.41M 785K Mar/2026
Ironwood Pharmaceuticals USD 583.99M 14.83M Dec/2024
Karyopharm Therapeutics USD 278.22M 278.22M Dec/2025
Lexicon Pharmaceuticals USD 49.68M 276K Mar/2026
MacroGenics USD 70M 256K Dec/2025
Moderna USD 603M 7M Mar/2026
Myriad Genetics USD 120.3M 400K Mar/2026
Pacira USD 367.66M 4.53M Mar/2026
PTC Therapeutics USD 286.94M 1.74B Mar/2026
Puma Biotechnology USD 10.87M 222K Jun/2025
Sarepta Therapeutics USD 838.16M 9.19M Mar/2026
Takeda JPY 4.37T 99.51B Mar/2026
Ultragenyx Pharmaceutical USD 1.13B 19M Mar/2026
Vanda Pharmaceuticals USD 3.15M 3.15M Dec/2024